SEARCH

SEARCH BY CITATION

References

  • 1
    Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795802.
  • 2
    Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157166.
  • 3
    Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997; 337: 373381.
  • 4
    Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 15651577.
  • 5
    Thomson BG, Robertson KA, Gowan D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 27032711.
  • 6
    Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 29622971.
  • 7
    Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999; 93: 36623671.
  • 8
    Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 18151822.
  • 9
    Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 29572961.
  • 10
    Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 16111618.
  • 11
    Michel G, Rocha V, Chevret S et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003; 102: 42904297.
  • 12
    Rubinstein P, Carrier C, Carpenter C et al. Graft selection in unrelated placental/umbilical cord blood (PCB) transplantation: influence and weight of HLA match and cell dose on engraftment and survival. Blood 2000; 96: 588a.
  • 13
    Stevens CE, Scaradavou A, Rubinstein P. Does patient age affect outcome in cord blood transplants? A retrospective analysis of 1101 transplants from the New York Blood Center's National Cord Blood Program. Blood 2002; 100: 641a.
  • 14
    Sanz FG, Saavedra S, Planelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 23322338.
  • 15
    Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003; 101: 47114713.
  • 16
    Ooi J, Iseki T, Takahashi S et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489491.
  • 17
    Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 11971205.
  • 18
    Rocha V, Chastang C, Laporte JP et al. Unrelated umbilical cord blood transplants in adults with hematologic malignancies. Blood 1998; 92: 144a.
  • 19
    Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med 2001; 344: 18601861.
  • 20
    Laporte JP, Lesage S, Portnoï MF et al. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience. Bone Marrow Transplant 1998; 22(Suppl 1):S7677.
  • 21
    Rocha V, Chastang C, Souillet G et al. Related cord blood transplant: the Eurocord experience from 78 transplants. Bone Marrow Transplant 1998; 21(Suppl 3):S5962.
  • 22
    Long GD, Laughlin M, Madan B et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 12: 772780.
  • 23
    Barker J, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer 2003; 3: 526532.
  • 24
    Kögler G, Sarnowski A, Wernet P. Volume reduction of cord blood by Hetastarch for long-term stem cell banking. Bone Marrow Transplant 1998; 22(Suppl 1):S1415.
  • 25
    Querol S, Gabarró M, Amat L et al. The placental blood program of the Barcelona Cord Blood Bank. Bone Marrow Transplant 1998; 22(Suppl 1):S35.
  • 26
    Jones J, Stevens CE, Rubinstein P et al. Obstetric predictors of placental/umbilical cord blood volume for transplantation. Am J Obstet Gynecol 2003; 188: 503509.
  • 27
    Kögler G, Somville T, Göbel U et al. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany. Klin Pädiatr 1999; 211: 224232.
  • 28
    Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995; 92: 1011910122.
  • 29
    Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213226.
  • 30
    Prat I, Hernández C, Muñoz M, et al. Organization of an umbilical cord blood transplant program. Haematologica 1998; 83: 667669.
  • 31
    Donaldson C, Buchanan R, Webster J et al. Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service. Bone Marrow Transplant 2000; 25: 899905.
  • 32
    Thierry D, Traineau R, Adam M et al. Hematopoietic stem cell potential from umbilical cord blood. Nouv Rev Fr Hematol 1990; 32: 439440.
  • 33
    Davey S, Armitage S, Rocha V et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 2004; 125: 358365.
  • 34
    Reboredo NM, Díaz A, Castro A et al. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 2000; 26: 12631270.
  • 35
    Ballen KK, Wilson M, Wuu J et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 2001; 27: 714.
  • 36
    Rubinstein P, Taylor PE, Scaradavou A et al. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells 1994; 20: 587596.
  • 37
    Dal Cortivo L, Marolleau JP, Gluckman E et al. The Paris Cord Blood Bank. Bone Marrow Transplant 1998; 22(Suppl 1):S11.
  • 38
    Socie G, Gluckman E, Carosella E et al. Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 1994; 83: 340344.
  • 39
    Briz M, Regidor C, Monteagudo D et al. Detection of maternal DNA in umbilical cord blood by polymerase chain reaction amplification of minisatellite sequences. Bone Marrow Transplant 1998; 21: 10971099.
  • 40
    Kurtzberg J, Graham M, Casey J et al. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20: 275283.
  • 41
    Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593602.
  • 42
    Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 17671777.
  • 43
    Weisdorf DJ. Bone marrow transplantation for acute lymphocytic leukemia (ALL). Leukemia 1997; 11(Suppl 4): S2022.
  • 44
    Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153166.
  • 45
    Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25;797799.
  • 46
    Shpall EJ, Quinones R, Guiller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368376.
  • 47
    Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex-vivo expanded UCB cells: results of a phase I trial using the Aastrom Replicell system. Blood 2003; 101: 50615067.
  • 48
    Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 18701871.
  • 49
    Fernández MN, Regidor C, Cabrera R et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535544.
  • 50
    Rizzieri DA, Long GD, Vredenburgh JJ et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 2001; 98: 34863488.
  • 51
    Barker JN, Weisdorf DJ, DeFor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 19151919.
  • 52
    Turner CW, Luzins J, Hutcheson C. A modified harvest technique for cord blood hematopoietic stem cells. Bone Marrow Transplant 1992; 10: 8991.
  • 53
    Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 27172722.
  • 54
    de Wynter E, Buck D, Hart C et al. CD34+ AC133+ cells isolated from cord blood are highly enriched in long-term culture initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998; 16: 387396.
  • 55
    Goussetis E, Theodosaki M, Paterakis G et al. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+ CD34bright and AC133dim/−CD34+ human cord blood cells. J Hematother Stem Cell Res 2000; 9: 827840.
  • 56
    Handgretinger R, Gordon PR, Leimig T et al. Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci 2003; 996: 141151.
  • 57
    Scaradavou A, Carrier C, Mollen N et al. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996; 88: 14941500.
  • 58
    Elchalal U, Fasouliotis SJ, Shtockheim D et al. Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. Am J Obstet Gynecol 2000; 182: 227232.
  • 59
    Screnci M, De Felice L, Carmini D et al. Does the type of delivery influence umbilical cord blood recovery? Bone Marrow Transplant 1995; 16: 631632.
  • 60
    Surbek DV, Schönfeld B, Tichelli A et al. Optimizing cord blood mononuclear cell yield: a randomized comparison of collection before vs. after placenta delivery. Bone Marrow Transplant 1998; 22: 311312.
  • 61
    Surbek DV, Visca E, Steinmann C et al. Umbilical cord blood collection before placental delivery during cesarean delivery increases cord blood volume and nucleated cell number available for transplantation. Am J Obstet Gynecol 2000; 183: 218221.
  • 62
    Solves P, Mirabet V, Larrea L et al. Comparison between two cord blood collection strategies. Acta Obstet Gynecol Scand 2003; 82: 439442.
  • 63
    Kurtzberg J, Issitt L, Caravan H et al. Cord blood collections ex utero are no different to cord blood collections in utero when performed by trained collection staff. Cytotherapy 2003; 5: 437a.